Clinical Trial

Study of Platelet Population Changes Under Circulatory Support With ECMO

Study acronym: ECMO-POP
Recruiting
View on ClinicalTrials.gov →
Summary
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.
Trial Details
NCT Number NCT07334457
Lead Sponsor University Hospital, Strasbourg, France
Conditions Cardiac Failure, Respiratory Failure
Enrollment 75 participants
Start Date 2025-03-11
Primary Completion 2027-03 (estimated)
Study Completion 2027-03-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-12